Historical record - last NADAC effective date: 12/21/2022
Product Information
ERYTHROMYCIN DR 500 MG TABLET is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $4.8465 per EA under NDC 69238147301. Its NADAC has been published 67 times since May 18, 2022.
FDA first approved this application on Jul 2, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
69238147301
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
12/21/2022
Active Ingredients
ERYTHROMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA210954FDA Approved
7/2/2019
TE Code
AB
On Market Since
7/7/2019
Pharmacological Classes
Price Statistics
The NADAC for ERYTHROMYCIN DR 500 MG TABLET has been published 67 times since May 18, 2022, and over the history we have for it it has declined 24.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.8465 per EA |
|---|---|
| All-time high | $6.3733 (Dec 14, 2022) |
| All-time low | $4.8465 (Dec 21, 2022) |
| Median price | $4.8465 |
| Average price | $5.5529 |
| Largest weekly change | -24.0% (Dec 21, 2022) |
| Weeks tracked | 67 |
| Tracking since | May 18, 2022 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-24.0%
Last surveyed Aug 23, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 48% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals NY LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Erythromycin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Macrolide Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ERYTHROMYCIN DR 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN DR 500 MG TABLET, manufactured by Amneal Pharmaceuticals NY LLC, is $4.8465 per EA (NDC 69238147301), effective Aug 23, 2023.
How has the price of ERYTHROMYCIN DR 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for ERYTHROMYCIN DR 500 MG TABLET has declined 24.0%. It has been tracked across 67 weekly CMS publications since May 18, 2022.
What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN DR 500 MG TABLET?
Since May 18, 2022, the NADAC for ERYTHROMYCIN DR 500 MG TABLET has ranged from a low of $4.8465 (Dec 21, 2022) to a high of $6.3733 (Dec 14, 2022), with a median of $4.8465 per EA.
Are there cheaper alternatives to ERYTHROMYCIN DR 500 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ERYTHROMYCIN 500 MG TABLET, is $2.5104 per EA — about 48% below ERYTHROMYCIN DR 500 MG TABLET.
Who manufactures ERYTHROMYCIN DR 500 MG TABLET?
ERYTHROMYCIN DR 500 MG TABLET (NDC 69238147301) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.